Twist Bioscience Corp. (TWST)
188.67
+0.62
(+0.33%)
USD |
NASDAQ |
Oct 02, 16:00
189.79
+1.12
(+0.59%)
After-Hours: 20:00
Twist Bioscience Gross Profit Margin (Quarterly) : 52.76% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.76% |
| March 31, 2026 | 51.59% |
| December 31, 2025 | 52.05% |
| September 30, 2025 | 51.35% |
| June 30, 2025 | 53.40% |
| March 31, 2025 | 49.60% |
| December 31, 2024 | 48.29% |
| September 30, 2024 | 45.13% |
| June 30, 2024 | 43.30% |
| March 31, 2024 | 41.01% |
| December 31, 2023 | 40.51% |
| September 30, 2023 | 36.63% |
| June 30, 2023 | 34.35% |
| March 31, 2023 | 30.76% |
| December 31, 2022 | 45.72% |
| September 30, 2022 | 44.88% |
| June 30, 2022 | 44.80% |
| March 31, 2022 | 38.26% |
| December 31, 2021 | 35.61% |
| September 30, 2021 | 40.72% |
| Date | Value |
|---|---|
| June 30, 2021 | 40.22% |
| March 31, 2021 | 39.02% |
| December 31, 2020 | 35.51% |
| September 30, 2020 | 45.80% |
| June 30, 2020 | 22.33% |
| March 31, 2020 | 29.71% |
| December 31, 2019 | 19.65% |
| September 30, 2019 | 21.29% |
| June 30, 2019 | 16.22% |
| March 31, 2019 | 13.04% |
| December 31, 2018 | -3.18% |
| September 30, 2018 | -8.16% |
| June 30, 2018 | -14.71% |
| March 31, 2018 | -31.28% |
| December 31, 2017 | -73.85% |
| September 30, 2017 | -97.03% |
| June 30, 2017 | -95.84% |
| March 31, 2017 | -146.0% |
| December 31, 2016 | -194.7% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.00K% |
| Intellia Therapeutics, Inc. | 72.58% |
| Prime Medicine, Inc. | -54.68% |
| Absci Corp. | -747.8% |
| 10X Genomics, Inc. | 74.36% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -29.62% |
| Return on Assets | -20.89% |
| Return on Invested Capital | -24.86% |
| Profit Margin (Quarterly) | -29.61% |
| Operating Margin (Quarterly) | -30.65% |
| Return on Net Operating Assets | -38.83% |